IntelliCyt Cy-Clone™ PLUS
[easy-total-shares align="center" share_text="SHARES" url="https://www.europeanpharmaceuticalreview.com/news/50057/intellicyt-cy-clone-plus/"][easy-social-share buttons="facebook,twitter,linkedin,print,mail,more,pinterest,stumbleupon,reddit,buffer,xing,whatsapp,flipboard" morebutton="3" morebutton_icon="plus" counters=0 style="icon" column="yes" columns="6" url="https://www.europeanpharmaceuticalreview.com/news/50057/intellicyt-cy-clone-plus/" text="IntelliCyt Cy-Clone™ PLUS"]
Posted: 27 March 2017 | | No comments yet
Cy-Clone PLUS together with the iQue Screener PLUS platform uses the power of high throughput flow cytometry…
The fastest way to the best clones
Introducing Cy-Clone™ PLUS—the only one assay, one platform method for rapidly identifying and selecting production clones. Traditionally ranked by IgG titer alone, Cy-Clone PLUS provides a more complete picture of the critical productivity attributes that drive optimal clone selection. The Cy-Clone PLUS Kit and the iQue® Screener PLUS platform combine IgG titer, cell viability, and cell count in every well of a 96-well plate in <5 minutes (384-wells < 20 minutes).
Find out how to accelerate your cell line development
